<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://www.clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/d7135ea6-2713-4cdb-9518-96b4e979b0db/E871350E-FC41-4BBA-9951-C39C75239326/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.newscientist.com/article/mg19626343.100" href="http://www.newscientist.com/article/mg19626343.100" style="font-size: 11px;">www.newscientist.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newscientist.com/article/mg19626343.100"><P>WILL genomics pioneer Craig Venter be the next Bill Gates, enjoying a Microsoft-like grip on a future industry based on synthetic forms of life? That was the claim of an advocacy group concerned about the social implications of technologies earlier this year, after Venter's institute applied for a patent on a synthetic "minimal genome" <A href="http://www.newscientist.com/channel/life/mg19426085.600-angry-reception-greets-patent-for-synthetic-life.html">(<I>New Scientist</I>, 16 June, p 13)</A>.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newscientist.com/article/mg19626343.100"><P>Now the Ottawa-based ETC Group is raising the alarm again. In the past few weeks, two patent applications by scientists at the J. Craig Venter Institute were published. These cover methods for <A target="nsarticle" href="http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=2&f=G&l=50&d=PG01&p=1&S1=Venter.IN.&OS=IN/Venter&RS=IN/Venter">making synthetic genomes</A> and for <A target="nsarticle" href="http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PG01&s1=20070269862&OS=20070269862&RS=20070269862">inserting whole or partial genomes</A> into natural or artificial cells. If granted with all their claims intact, the patents would give rights to a broad sweep of techniques in synthetic biology - an emerging field that aims to build biological devices constructed in part from chemically synthesised DNA.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.newscientist.com/article/mg19626343.100">This is a case of using the patent system as a type of futures market to take out options,"</blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/E871350E-FC41-4BBA-9951-C39C75239326/blog/" title="blog or email this clip"><img src="http://content9.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks:  Amplify.com - Don't just share the news...Amplify it!